Nifty

:

22147.00

Sensex

:

73088.33

151.15 (0.69%)
599.34 (0.83%)

Login

Nifty
Sensex

:
:

22147.00
73088.33

151.15 (0.69%)
599.34 (0.83%)

Medplus Health Services Ltd.

Pharmaceuticals & Drugs

Rating :

46/99

BSE: 543427 | NSE: MEDPLUS

Watchlist

NSE BSE

694.40

19-Apr-2024

Open
High
Low
Previous Close

680.20
700.05
680.20
696.25

Volume
Traded Value (lacs)
52 Week High
52 Week Low

70075
484.95
978.00
598.60

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

8,293.47
141.39
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

8,097.45
N/A
5.38

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

55.73
-
14.09

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
4.18

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-7.98

P:E (Median)

8 Years
5 Years
3 Years

-
-
186.77

P:BV (Average)

8 Years
5 Years
3 Years

-
-
7.05

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
32.14

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 148.10 57.24 158.74% 98.67 42.45 132.44% 71.89 27.29 163.43% 86.95 38.82 123.98%
Expenses 137.31 53.50 156.65% 92.40 42.88 115.49% 69.57 28.82 141.39% 75.53 41.06 83.95%
EBITDA 10.79 3.74 188.50% 6.27 -0.42 - 2.32 -1.54 - 11.42 -2.24 -
EBIDTM 7.29% 6.54% 6.36% -1.00% 3.23% -5.64% 13.13% -5.77%
Other Income 1.82 4.07 -55.28% 1.76 4.26 -58.69% 1.81 5.37 -66.29% 2.54 6.21 -59.10%
Interest 2.10 1.79 17.32% 2.11 1.46 44.52% 2.08 1.25 66.40% 2.05 1.19 72.27%
Depreciation 6.27 4.24 47.88% 5.96 3.20 86.25% 5.54 2.54 118.11% 5.33 1.86 186.56%
PBT 4.24 1.78 138.20% -0.04 -0.82 - -3.49 0.04 - 6.59 0.92 616.30%
Tax 1.05 1.16 -9.48% 0.00 0.00 0 0.00 0.00 0 0.88 0.00 0
PAT 3.19 0.62 414.52% -0.04 -0.82 - -3.49 0.04 - 5.71 0.92 520.65%
PATM 2.15% 1.08% -0.04% -1.93% -4.85% 0.15% 6.56% 2.38%
EPS 0.27 0.05 440.00% 0.00 -0.07 - -0.29 0.00 - 0.48 0.08 500.00%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 1,441.47 1,190.31 21.10% 1,408.59 1,120.63 25.70% 1,284.30 993.65 29.25% 1,252.98 965.91 29.72%
Expenses 1,349.69 1,118.59 20.66% 1,323.50 1,060.96 24.75% 1,212.95 941.01 28.90% 1,171.35 913.63 28.21%
EBITDA 91.78 71.72 27.97% 85.09 59.67 42.60% 71.34 52.64 35.52% 81.63 52.27 56.17%
EBIDTM 6.37% 6.03% 6.04% 5.32% 5.56% 5.30% 6.51% 5.41%
Other Income 9.79 11.36 -13.82% 10.37 10.89 -4.78% 9.39 10.13 -7.31% 13.69 13.05 4.90%
Interest 24.50 21.08 16.22% 23.54 19.87 18.47% 23.27 19.81 17.47% 22.27 18.58 19.86%
Depreciation 57.11 45.79 24.72% 55.47 41.87 32.48% 52.41 38.10 37.56% 55.80 34.11 63.59%
PBT 19.96 16.21 23.13% 16.44 8.82 86.39% 5.05 4.87 3.70% 17.25 12.63 36.58%
Tax 6.26 2.83 121.20% 1.90 2.34 -18.80% 1.29 1.19 8.40% -9.30 1.20 -
PAT 13.71 13.38 2.47% 14.54 6.48 124.38% 3.76 3.68 2.17% 26.56 11.43 132.37%
PATM 0.95% 1.12% 1.03% 0.58% 0.29% 0.37% 2.12% 1.18%
EPS 1.15 1.12 2.68% 1.22 0.55 121.82% 0.32 0.27 18.52% 2.23 0.98 127.55%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Net Sales 405.61 213.93 145.71 68.31 61.11 2.55 2.59 3.04 382.11 292.66 204.27 Net Sales Growth 144.64% 46.82% 113.31% 11.78% 2296.47% -1.54% -14.80% -99.20% 30.56% 43.27% Cost Of Goods Sold 304.25 156.87 118.57 50.24 43.53 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit 101.36 57.05 27.15 18.08 17.59 2.55 2.59 3.04 382.11 292.66 204.27 GP Margin 24.99% 26.67% 18.63% 26.47% 28.78% 100% 100% 100% 100% 100% 100% Total Expenditure 374.81 207.67 142.41 77.11 86.29 4.14 4.25 6.81 383.54 313.26 223.71 Power & Fuel Cost - 2.57 0.57 0.18 0.06 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 1.20% 0.39% 0.26% 0.10% 0% 0% 0% 0% 0% 0% Employee Cost - 28.14 13.73 22.57 6.91 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 13.15% 9.42% 33.04% 11.31% 0% 0% 0% 0% 0% 0% Manufacturing Exp. - 1.45 0.51 0.32 1.69 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0.68% 0.35% 0.47% 2.77% 0% 0% 0% 0% 0% 0% General & Admin Exp. - 11.34 4.92 3.48 1.70 4.14 4.25 6.81 383.54 313.26 223.71 % Of Sales - 5.30% 3.38% 5.09% 2.78% 162.35% 164.09% 224.01% 100.37% 107.04% 109.52% Selling & Distn. Exp. - 6.28 3.41 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 2.94% 2.34% 0.10% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 1.00 0.70 0.26 32.41 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0.47% 0.48% 0.38% 53.04% 0% 0% 0% 0% 0% 0% EBITDA 30.80 6.26 3.30 -8.80 -25.18 -1.59 -1.66 -3.77 -1.43 -20.60 -19.44 EBITDA Margin 7.59% 2.93% 2.26% -12.88% -41.20% -62.35% -64.09% -124.01% -0.37% -7.04% -9.52% Other Income 7.93 23.18 9.54 2.11 1.92 0.22 0.47 1.81 2.43 2.89 5.46 Interest 8.34 6.54 2.63 0.56 0.27 1.93 0.51 0.16 0.84 0.00 0.00 Depreciation 23.10 15.31 4.63 1.31 0.84 0.24 0.28 0.33 1.00 1.51 0.96 PBT 7.30 7.59 5.58 -8.57 -24.36 -3.54 -1.99 -2.45 -0.83 -19.22 -14.95 Tax 1.93 2.04 0.00 0.00 0.51 0.00 0.00 0.00 0.00 -0.47 0.21 Tax Rate 26.44% 26.88% 0.00% 0.00% -2.09% 0.00% 0.00% 0.00% 0.00% 2.45% -1.40% PAT 5.37 5.54 5.58 -8.57 -24.87 -7.09 -1.99 -2.45 -8.06 -18.75 -15.16 PAT before Minority Interest 5.37 5.54 5.58 -8.57 -24.87 -7.09 -1.99 -2.45 -8.06 -18.75 -15.16 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.32% 2.59% 3.83% -12.55% -40.70% -278.04% -76.83% -80.59% -2.11% -6.41% -7.42% PAT Growth 606.58% -0.72% - - - - - - - - EPS 0.45 0.46 0.47 -0.72 -2.08 -0.59 -0.17 -0.21 -0.67 -1.57 -1.27

Description TTM Mar 23 Mar 22 Mar 21 Mar 20
Net Sales 5,387.34 4,557.58 3,779.28 3,069.27 2,870.60 Net Sales Growth 26.15% 20.59% 23.13% 6.92% Cost Of Goods Sold 4,207.71 3,557.69 2,982.37 2,425.24 2,336.54 Gross Profit 1,179.63 999.89 796.90 644.03 534.07 GP Margin 21.90% 21.94% 21.09% 20.98% 18.60% Total Expenditure 5,057.49 4,276.21 3,490.40 2,840.05 2,736.93 Power & Fuel Cost - 31.71 17.78 13.29 13.70 % Of Sales - 0.70% 0.47% 0.43% 0.48% Employee Cost - 545.13 393.92 338.65 272.40 % Of Sales - 11.96% 10.42% 11.03% 9.49% Manufacturing Exp. - 6.19 4.57 6.18 8.28 % Of Sales - 0.14% 0.12% 0.20% 0.29% General & Admin Exp. - 62.06 39.66 24.88 21.00 % Of Sales - 1.36% 1.05% 0.81% 0.73% Selling & Distn. Exp. - 67.76 47.35 29.27 47.58 % Of Sales - 1.49% 1.25% 0.95% 1.66% Miscellaneous Exp. - 5.67 4.75 2.54 37.43 % Of Sales - 0.12% 0.13% 0.08% 1.30% EBITDA 329.84 281.37 288.88 229.22 133.67 EBITDA Margin 6.12% 6.17% 7.64% 7.47% 4.66% Other Income 43.24 46.08 31.36 21.55 17.28 Interest 93.58 98.72 82.94 67.40 46.80 Depreciation 220.79 181.56 119.36 88.27 74.81 PBT 58.70 47.16 117.94 95.10 29.36 Tax 0.15 -2.94 23.23 31.99 27.57 Tax Rate 0.26% -6.23% 19.70% 33.64% 93.90% PAT 58.57 49.76 95.81 63.86 1.79 PAT before Minority Interest 58.65 50.10 94.72 63.11 1.79 Minority Interest 0.08 -0.34 1.09 0.75 0.00 PAT Margin 1.09% 1.09% 2.54% 2.08% 0.06% PAT Growth 67.49% -48.06% 50.03% 3,467.60% EPS 4.90 4.16 8.02 5.34 0.15

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Shareholder's Funds 1,141.28 1,112.78 517.48 395.61 135.10 142.19 144.18 146.48 93.78 107.48 Share Capital 23.86 23.86 0.45 0.19 0.17 0.17 0.17 0.17 0.15 0.15 Total Reserves 1,086.98 1,077.53 468.38 159.28 130.40 137.50 139.49 141.93 88.58 107.33 Non-Current Liabilities 84.69 42.40 7.34 3.45 0.08 0.08 0.07 0.00 15.77 8.58 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.77 8.58 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 3.88 0.71 0.88 1.10 0.08 0.08 0.07 0.00 0.00 0.00 Current Liabilities 48.01 32.27 23.60 16.17 10.77 9.32 1.15 5.69 29.52 20.78 Trade Payables 12.79 5.53 2.36 1.11 0.73 0.75 1.01 2.74 25.21 19.63 Other Current Liabilities 34.19 26.01 20.58 14.61 0.18 0.37 0.11 2.79 3.92 0.48 Short Term Borrowings 0.00 0.00 0.00 0.00 8.00 8.00 0.00 0.00 0.00 0.00 Short Term Provisions 1.03 0.74 0.66 0.45 1.85 0.20 0.02 0.16 0.39 0.67 Total Liabilities 1,273.98 1,187.45 548.42 415.23 145.95 151.59 145.40 152.17 139.07 136.84 Net Block 179.41 85.02 22.68 7.17 1.19 1.57 1.98 2.38 4.86 8.08 Gross Block 201.26 92.46 25.91 9.21 2.18 2.36 2.64 2.72 6.31 9.18 Accumulated Depreciation 21.85 7.45 3.23 2.04 0.99 0.80 0.66 0.34 1.46 1.10 Non Current Assets 1,123.40 530.12 441.94 390.32 145.54 147.55 142.72 105.85 6.70 8.79 Capital Work in Progress 17.91 15.52 2.01 0.95 0.00 0.00 0.00 0.00 0.31 0.68 Non Current Investment 917.16 418.45 408.50 381.09 143.63 145.33 139.48 103.48 1.54 0.03 Long Term Loans & Adv. 8.92 11.13 8.75 1.12 0.71 0.65 1.25 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.00 Current Assets 150.58 657.34 106.48 24.90 0.40 4.04 2.68 46.32 132.37 128.04 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 6.69 3.90 4.79 3.94 0.12 0.12 0.12 0.15 20.50 17.95 Sundry Debtors 37.61 21.29 11.51 8.60 0.14 0.13 0.09 0.15 84.48 83.74 Cash & Bank 90.16 7.44 86.68 10.74 0.03 2.16 2.43 28.62 5.88 3.32 Other Current Assets 16.12 21.57 0.41 0.33 0.11 1.63 0.05 17.40 21.52 23.04 Short Term Loans & Adv. 14.32 603.14 3.10 1.30 0.11 1.62 0.03 16.92 17.91 19.58 Net Current Assets 102.57 625.06 82.88 8.73 -10.36 -5.28 1.53 40.63 102.85 107.26 Total Assets 1,273.98 1,187.46 548.42 415.22 145.94 151.59 145.40 152.17 139.07 136.83

Description Mar 23 Mar 22 Mar 21 Mar 20
Shareholder's Funds 1,491.18 1,417.77 730.55 527.80 Share Capital 23.86 23.86 0.45 0.19 Total Reserves 1,436.88 1,382.52 681.45 291.47 Non-Current Liabilities 797.40 647.39 381.01 298.35 Secured Loans 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 Long Term Provisions 61.33 94.94 18.35 17.74 Current Liabilities 476.58 559.01 444.84 481.09 Trade Payables 260.14 246.23 148.09 234.15 Other Current Liabilities 189.35 148.29 111.39 122.35 Short Term Borrowings 0.00 142.68 135.24 105.05 Short Term Provisions 27.09 21.80 50.12 19.54 Total Liabilities 2,764.48 2,623.65 1,556.95 1,308.54 Net Block 1,137.96 798.73 517.30 419.46 Gross Block 1,617.39 1,114.11 739.16 689.67 Accumulated Depreciation 479.43 315.38 221.86 270.21 Non Current Assets 1,283.77 991.95 603.97 492.76 Capital Work in Progress 25.47 20.45 5.54 4.94 Non Current Investment 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 120.33 172.75 81.08 68.33 Other Non Current Assets 0.00 0.02 0.05 0.04 Current Assets 1,480.72 1,631.71 952.98 815.78 Current Investments 0.03 0.03 0.03 0.25 Inventories 1,144.09 914.98 749.96 643.55 Sundry Debtors 8.65 6.04 5.37 6.40 Cash & Bank 283.83 34.41 118.59 140.69 Other Current Assets 44.12 31.74 7.69 6.71 Short Term Loans & Adv. 32.94 644.51 71.34 18.16 Net Current Assets 1,004.14 1,072.70 508.14 334.69 Total Assets 2,764.49 2,623.66 1,556.95 1,308.54

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Cash From Operating Activity 11.40 -18.37 -6.24 2.89 -1.80 -0.64 -5.61 -4.05 -6.89 -57.28 PBT 7.59 5.58 -8.57 -24.36 -7.09 -1.99 -2.45 -8.06 -19.22 -14.95 Adjustment 3.39 0.65 8.22 31.25 0.16 0.03 -0.83 8.71 7.53 -0.35 Changes in Working Capital 2.24 -22.59 -6.17 -4.79 -0.18 0.43 -3.86 -4.71 4.81 -41.93 Cash after chg. in Working capital 13.22 -16.36 -6.52 2.10 -7.11 -1.53 -7.13 -4.05 -6.88 -57.22 Interest Paid 0.00 0.00 0.00 0.00 1.93 0.51 0.00 0.00 0.00 0.00 Tax Paid -1.81 -2.01 0.28 0.79 -0.21 0.29 1.52 0.00 -0.02 -0.05 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 3.59 0.09 0.00 0.00 0.00 0.00 Cash From Investing Activity 31.72 -635.99 -14.77 -196.64 1.54 -7.14 -20.40 -11.10 0.71 49.10 Net Fixed Assets -111.19 -80.06 -17.76 -7.98 0.18 0.28 0.08 3.90 3.24 -4.66 Net Investments -498.71 -9.95 -27.41 -237.46 1.70 -5.85 -36.00 -101.94 -1.51 5.86 Others 641.62 -545.98 30.40 48.80 -0.34 -1.57 15.52 86.94 -1.02 47.90 Cash from Financing Activity -8.36 568.63 96.94 203.96 -1.87 7.51 -0.16 43.39 6.25 8.37 Net Cash Inflow / Outflow 34.77 -85.74 75.94 10.21 -2.13 -0.27 -26.18 28.24 0.07 0.19 Opening Cash & Equivalents 0.94 86.68 10.74 0.53 2.16 2.43 28.61 0.37 0.31 0.12 Closing Cash & Equivalent 35.70 0.94 86.68 10.74 0.03 2.16 2.43 28.61 0.37 0.31

Description Mar 23 Mar 22 Mar 21 Mar 20
Cash From Operating Activity 90.41 169.89 2.89 -6.59 PBT 47.16 117.94 95.10 29.36 Adjustment 272.76 187.88 182.28 155.41 Changes in Working Capital -215.58 -102.37 -245.77 -176.50 Cash after chg. in Working capital 104.34 203.45 31.61 8.27 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -13.94 -33.56 -28.71 -14.86 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity 429.44 -703.13 -34.55 -27.55 Net Fixed Assets -111.19 -80.06 -17.76 Net Investments -498.71 -9.95 -27.41 Others 1,039.34 -613.12 10.62 Cash from Financing Activity -170.25 440.43 -5.63 89.83 Net Cash Inflow / Outflow 349.60 -92.81 -37.28 55.69 Opening Cash & Equivalents -121.23 -28.42 8.87 -46.82 Closing Cash & Equivalent 228.38 -121.23 -28.42 8.87

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Book Value (Rs.) 93.11 92.32 2092.97 8220.31 7761.29 8182.90 8301.20 8446.76 5835.11 7068.27 ROA 0.45% 0.64% -1.78% -8.20% -4.77% -1.34% -1.65% -5.53% -13.59% -11.26% ROE 0.50% 0.71% -2.73% -14.80% -5.29% -1.44% -1.74% -6.98% -19.11% -13.18% ROCE 1.25% 1.01% -1.75% -8.30% -3.52% -1.00% -1.57% -5.64% -17.04% -12.53% Fixed Asset Turnover 1.57 2.63 3.98 11.59 1.12 1.03 1.13 84.62 37.78 30.34 Receivable days 46.56 38.38 52.46 31.88 19.40 15.57 14.06 40.42 104.89 114.79 Inventory Days 8.37 10.16 22.76 12.43 17.35 16.63 16.21 9.87 23.98 24.48 Payable days 21.31 12.15 12.61 22.26 1130.61 1132.69 2107.52 5120.81 4171.22 4147.62 Cash Conversion Cycle 33.62 36.39 62.61 22.06 -1093.85 -1100.48 -2077.26 -5070.53 -4042.34 -4008.35 Total Debt/Equity 0.00 0.00 0.00 0.00 0.06 0.06 0.00 0.00 0.18 0.08 Interest Cover 2.16 3.12 -14.16 -89.56 -2.67 -2.89 -14.12 -8.62 0.00 0.00

Description Mar 23 Mar 22 Mar 21 Mar 20
Book Value (Rs.) 122.44 117.89 3044.19 15034.43 ROA 1.86% 4.51% 4.40% 0.18% ROE 3.50% 9.07% 12.96% 0.59% ROCE 9.56% 16.56% 21.69% 14.34% Fixed Asset Turnover 3.39 4.13 4.38 6.75 Receivable days 0.58 0.54 0.69 0.96 Inventory Days 81.27 79.28 81.18 65.97 Payable days 25.98 24.13 28.76 24.12 Cash Conversion Cycle 55.87 55.69 53.10 42.81 Total Debt/Equity 0.00 0.10 0.20 0.36 Interest Cover 1.48 2.42 2.41 1.63

Top Investors:

lavender rose investment limited

pi opportunities fund i

nippon life india trustee ltd-a/c nippon india pha

sbi focused equity fund

arisaig asia fund limited

government of singapore

steadview capital mauritius limited

pravesa holding private limited

fidelity funds - india focus fund

goldman sachs funds - goldman sachs india equity p

Annual Reports:

News Update:

Medplus Health Servi - Quarterly Results
2nd Feb 2024, 17:33 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback